IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.530
-0.030 (-1.92%)
Apr 28, 2026, 4:00 PM EDT - Market closed
IN8bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 15 | 23 | 19 | 60 | 57 | 82 | |
| Market Cap Growth | 21.90% | 22.52% | -68.76% | 5.43% | -31.25% | - | |
| Enterprise Value | -9 | 15 | 20 | 52 | 34 | 44 | |
| Last Close Price | 1.53 | 2.34 | 7.72 | 41.40 | 69.30 | 131.70 | |
| PB Ratio | 0.54 | 0.83 | 1.29 | 2.39 | 2.49 | 2.16 | |
| P/TBV Ratio | 0.55 | 0.83 | 1.29 | 2.39 | 2.49 | 2.16 | |
| Debt / Equity Ratio | 0.10 | 0.10 | 0.35 | 0.20 | 0.26 | 0.06 | |
| Net Debt / Equity Ratio | -0.88 | -0.88 | -0.42 | -0.66 | -0.54 | -0.91 | |
| Net Debt / EBITDA Ratio | 1.34 | 1.34 | 0.22 | 0.57 | 0.44 | 2.47 | |
| Net Debt / FCF Ratio | 1.91 | 1.91 | 0.25 | 0.69 | 0.44 | 2.51 | |
| Quick Ratio | 8.57 | 8.57 | 3.61 | 3.95 | 3.12 | 16.41 | |
| Current Ratio | 8.82 | 8.82 | 4.08 | 4.57 | 3.82 | 17.28 | |
| Return on Equity (ROE) | -92.49% | -92.49% | -154.44% | -125.90% | -93.64% | -51.87% | |
| Return on Assets (ROA) | -46.64% | -46.64% | -67.70% | -56.81% | -47.37% | -29.01% | |
| Return on Capital Employed (ROCE) | -68.20% | -68.20% | -165.70% | -107.10% | -104.80% | -36.70% | |
| Earnings Yield | -129.03% | -85.11% | -163.26% | -50.29% | -50.39% | -17.80% | |
| FCF Yield | -84.38% | -55.65% | -130.54% | -40.12% | -49.16% | -16.78% | |
| Buyback Yield / Dilution | -145.07% | -145.07% | -79.30% | -42.43% | -110.32% | -191.59% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.